Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Annie Fourrier"'
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background WHO pharmacovigilance indicators have been recommended as a useful tool towards improving pharmacovigilance activities. Nigeria with a myriad of medicines related issues is encouraging the growth of pharmacovigilance at peripheral
Externí odkaz:
https://doaj.org/article/4d90233816de4b0382e0d45af0948d4a
Autor:
Isabelle Carrière, Joanna Norton, Amandine Farré, Marilyn Wyart, Christophe Tzourio, Pernelle Noize, Karine Pérès, Annie Fourrier-Réglat, Karen Ritchie, Marie Laure Ancelin
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Cognitive impairment is very common in late-life depression, principally affecting executive skills and information processing speed. The aim of the study was to examine the effect of antidepressant treatment on cognitive performa
Externí odkaz:
https://doaj.org/article/d5c26c543b2940d3bfefd8978d5bb2e5
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Background: Our aim in this study was to evaluate the effect of a combined educational intervention and year-long monthly text message reinforcements via the Short Messaging System (SMS) on the knowledge, attitude and practice (KAP) of healthcare pro
Externí odkaz:
https://doaj.org/article/bc59311bf6804ccaa609a923cbb757fa
Autor:
Mélanie Née, Marta Avalos, Audrey Luxcey, Benjamin Contrand, Louis-Rachid Salmi, Annie Fourrier-Réglat, Blandine Gadegbeku, Emmanuel Lagarde, Ludivine Orriols
Publikováno v:
PLoS Medicine, Vol 14, Iss 7, p e1002347 (2017)
BackgroundWhile some medicinal drugs have been found to affect driving ability, no study has investigated whether a relationship exists between these medicines and crashes involving pedestrians. The aim of this study was to explore the association be
Externí odkaz:
https://doaj.org/article/7542d56761bb4cafaada40bbc3f023dd
Autor:
Justine Perino, Marie Tournier, Clément Mathieu, Louis Letinier, Alexandre Peyré, Garance Perret, Edwige Pereira, Annie Fourrier‐Réglat, Clothilde Pollet, Mélina Fatseas, Christophe Tzourio, Amélie Daveluy
Publikováno v:
Fundamental & Clinical Pharmacology. 36:908-914
Little is known about psychoactive substance use in students, apart from tobacco, alcohol, and cannabis. This study investigated the prevalence of substance use and overlap between various psychoactive substances in students. This cross-sectional stu
Autor:
Pernelle Noize, Jean-Philippe Joseph, Driss Berdaï, Nicolas Rousselot, Annie Fourrier-Réglat, Pauline Bosco-Lévy
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.04.015⟩
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.04.015⟩
Summary Aim To describe the ambulatory changes in drug prescriptions 3 months after hospital discharge among elderly patients aged 75 and over, and to identify the reasons for these changes. Methods A prospective cohort study was conducted on subject
Publikováno v:
Kanem Journal Medical Sciences. 15:54-64
Background: In Nigeria, reporting pharmacovigilance issues including adverse drug reactions (ADRs) from health facilities is encouraged especially by health care professionals (HCPs). Objectives: This study assessed the knowledge, attitude and practi
Autor:
Régis Lassalle, E. Bignon, Antonio Sa Cunha, Nicholas Moore, Pernelle Noize, Alain Monnereau, Eric Francois, Annie Fourrier-Réglat, Magali Rouyer, Jérémy Jové, Cécile Droz-Perroteau, Denis Smith
Publikováno v:
British Journal of Clinical Pharmacology. 87:1120-1128
AIMS Poor efficacy has been reported for patients with BRAF mutations for metastatic colorectal cancer (mCRC). METHODS EREBUS is a French cohort study of wild-type (wt) KRAS unresectable mCRC patients initiating a first-line treatment with cetuximab
Autor:
Janet, Sultana, Salvatore, Crisafulli, Mariana, Almas, Ippazio Cosimo, Antonazzo, Esme, Baan, Claudia, Bartolini, Maria Paola, Bertuccio, Fedele, Bonifazi, Annalisa, Capuano, Antonella, Didio, Vera, Ehrenstein, Mariagrazia, Felisi, Carmen, Ferrajolo, Andrea, Fontana, Remy, Francisca, Annie, Fourrier-Reglat, Joan, Fortuny, Rosa, Gini, Giulia, Hyeraci, Christel, Hoeve, Christos, Kontogiorgis, Valentina, Isgrò, Panagiotis-Nikolaos, Lalagkas, Luca, L'Abbate, Deborah, Layton, Annalisa, Landi, Silvia, Narduzzi, Leonardo, Roque Pereira, Georgios, Poulentzas, Concetta, Rafaniello, Giuseppe, Roberto, Giulia, Scondotto, Liberata, Sportiello, Maddalena, Toma, Massoud, Toussi, Katia, Verhamme, Elisabetta, Volpe, Gianluca, Trifirò
Publikováno v:
Sultana, J, Crisafulli, S, Almas, M, Antonazzo, I C, Baan, E, Bartolini, C, Bertuccio, M P, Bonifazi, F, Capuano, A, Didio, A, Ehrenstein, V, Felisi, M, Ferrajolo, C, Fontana, A, Francisca, R, Fourrier-Reglat, A, Fortuny, J, Gini, R, Hyeraci, G, Hoeve, C, Kontogiorgis, C, Isgrò, V, Lalagkas, P N, L'Abbate, L, Layton, D, Landi, A, Narduzzi, S, Roque Pereira, L, Poulentzas, G, Rafaniello, C, Roberto, G, Scondotto, G, Sportiello, L, Toma, M, Toussi, M, Verhamme, K, Volpe, E, Trifirò, G & On behalf the Working Group 3 of ENCePP (Inventory of EU data sources and methodological approaches for multisource studies) 2022, ' Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 ', Pharmacoepidemiology and Drug Safety, vol. 31, no. 6, pp. 689-705 . https://doi.org/10.1002/pds.5413
Pharmacoepidemiology and Drug Safety, 31(6), 689-705. John Wiley & Sons Ltd.
Pharmacoepidemiology and Drug Safety, 31(6), 689-705. John Wiley & Sons Ltd.
Background: The European post-authorisation study (EU PAS) register is a repository launched in 2010 by the European Medicines Agency (EMA). All EMA-requested PAS, commonly observational studies, must be recorded in this register. Multi-database stud
Autor:
Annie Fourrier-Réglat, Maïder Coppry, Driss Berdaï, Françoise Haramburu, Anne-Marie Rogues, Ghada Miremont-Salamé, Stéphanie Duret, Pernelle Noize
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2021, ⟨10.1111/fcp.12735⟩
Fundamental and Clinical Pharmacology, Wiley, 2021, ⟨10.1111/fcp.12735⟩
Owing to a broad spectrum and low cost antimicrobial, cotrimoxazole is largely prescribed. However, its use is associated with various adverse drug reactions (ADRs) that warrant to ensure rational prescribing. This study aimed to describe spontaneous